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Abstract
Background: Gene set analysis (in a form of functionally related genes or pathways) has become the method of
choice for analyzing omics data in general and gene expression data in particular. There are many statistical methods
that either summarize gene-level statistics for a gene set or apply a multivariate statistic that accounts for intergene
correlations. Most available methods detect complex departures from the null hypothesis but lack the ability to identify
the specific alternative hypothesis that rejects the null.
Results: GSAR (Gene Set Analysis in R) is an open-source R/Bioconductor software package for gene set analysis (GSA).
It implements self-contained multivariate non-parametric statistical methods testing a complex null hypothesis against
specific alternatives, such as differences in mean (shift), variance (scale), or net correlation structure. The package also
provides a graphical visualization tool, based on the union of two minimum spanning trees, for correlation networks to
examine the change in the correlation structures of a gene set between two conditions and highlight influential genes
(hubs).
Conclusions: Package GSAR provides a set of multivariate non-parametric statistical methods that test a complex null
hypothesis against specific alternatives. The methods in package GSAR are applicable to any type of omics data that
can be represented in a matrix format. The package, with detailed instructions and examples, is freely available under
the GPL (> = 2) license from the Bioconductor web site.
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Background
The idea of considering functional units (e.g., molecular
pathways) instead of individual components (e.g., genes)
in studying omics data was first employed by Mootha
and colleagues [1], in analyzing microarray gene expres-
sion data of diabetic subjects against healthy controls.
While analysis of individual gene expressions did not de-
tect any significant changes, the pathway level approach
named Gene Set Enrichment Analysis (GSEA) indicated
that the group of genes involved in oxidative phosphor-
ylation was overall under-expressed in diabetics although
individual genes were on average only 20% under-
expressed in diabetics [1]. Since that time, many meth-
odologies for finding differentially expressed gene sets
have been suggested and are collectively named Gene
Set Analysis (GSA) approaches [2, 3]. The benefits of
pathways analysis can be summarized as follows. First,
pathway level analysis incorporates accumulated bio-
logical knowledge into the results and conveys more ex-
planatory power than a long list of seemingly unrelated
differentially expressed genes [3]. Second, pathway ana-
lysis accounts for intergene correlations and facilitates
the detection of small or moderate changes in genes ex-
pression that could be overlooked by univariate tests.
Third, by arranging genes in pathways (gene sets) the
number of simultaneously tested hypotheses is reduced,
increasing the detection power after applying correction
for multiple testing. These benefits made pathway ana-
lysis the method of choice in analyzing omics data in
general and gene expression data in particular.
GSA approaches can be either competitive or self-
contained. Competitive approaches compare a gene set
in two conditions against its complement that consists
of all the genes in the dataset excluding the genes in
the set itself, and self-contained approaches test if a
gene set is differentially expressed between two
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experimental conditions. Some competitive approaches
can be influenced by data filtering and the size of the
dataset [4] while others can be influenced by the pro-
portion of up-regulated and down-regulated genes in a
gene set between two experimental conditions [5].
While competitive approaches test the same alternative
hypothesis against null hypothesis, self-contained ap-
proaches provide the flexibility of testing different al-
ternative hypotheses that may correspond to different
biological phenomena thus increasing the biological in-
terpretability of experimental results. We distinguish
the three major alternative hypotheses that can be tested by
GSA approaches: (1) differential expression (DE); (2) differ-
ential variability (DV); and (3) differential co-expression or
correlation (DC) of gene sets between two conditions.
Package GSAR (Gene Set Analysis in R) provides a set of
self-contained non-parametric multivariate GSA methods
that test each of these three different hypotheses.
The majority of GSA methods were developed to iden-
tify gene sets with differences in mean gene expressions
between two conditions for microarray or RNA-seq data.
Some DE tests were true multivariate methods (e.g.,
ROAST [6]) while others aggregate the outcome of gene-
level univariate tests (e.g., SAM-GS [7]). N-statistic [8]
tests more general alternative hypothesis whether two
multivariate distributions are different. Detailed discussion
and comparative power analysis for selected methods is
presented in [5, 9]. Package GSAR implements one multi-
variate method (WWtest) to identify differences in distri-
butions between two conditions and two non-parametric
multivariate methods to identify differences in mean ex-
pressions (KStest and MDtest) using sample ranking based
on the minimum spanning trees (MSTs) [10]. The analysis
of DV for individual genes identifies genes with significant
changes in expression variance between two conditions
[11–15]. The DV analysis frequently complements or
provides more relevant explanations for biological phe-
nomena than simple difference in mean expressions.
For example, a theoretical model for evolutionary fitness
suggested that increased gene expression variability is a
defining characteristic of cancer [16]. This suggestion was
further supported by the observation of increased variabil-
ity in DNA methylation of specific genes across five differ-
ent cancer types [17]. Moreover, some genes were found
to show consistently hyper-variability in tumors of differ-
ent origins as compared to normal samples [18] and such
genes can serve as a robust molecular signature for mul-
tiple cancer types [18, 19]. Although software packages for
univariate methods testing DV are available, to the best of
our knowledge multivariate methods for gene set DV ana-
lysis are non-existing. Package GSAR implements two
non-parametric DV approaches: (1) an approach that uses
the aggregation of P-values from univariate F-tests as a
test statistic and sample permutations to estimate the null
distribution of the statistic; and (2) a multivariate
approach that tests the hypothesis of differential p-
dimensional sample variability between two conditions
using MST-based sample ranking with two different
statistics [10].
In addition to tests of differential mean and variance,
GSAR implements the Gene Set Net Correlation Ana-
lysis (GSNCA) method that tests a multivariate null hy-
pothesis that there is no change in the net correlation
structure of a gene set between two conditions [20]. It
examines how the regulatory relationships and concord-
ance between gene expressions vary between phenotypes.
GSA approaches for identifying the differential gene set
co-expression (correlation) have been also described in lit-
erature. For example, Gene Sets Co-expression Analysis
(GSCA) aggregates the pairwise correlation differences
between two conditions [21], while other methods such
as the differentially Co-expressed gene Sets (dCoxS) ag-
gregates differences in relative entropy [22]. Other ap-
proaches for the differential co-expression analysis of
gene sets account for changes in aggregated measures
of pairwise correlations [23, 24]. Yet another category
of methods such as the Co-expression Graph Analysis
(CoGA) identifies co-expressed gene sets by testing the
equality of spectral distributions [25]. For each experi-
mental condition CoGA constructs a full network from
pairwise correlations and compares the structural prop-
erties of the two networks by applying Jensen-Shannon
divergence as a distance measure between the graph
spectrum distributions [25, 26]. Package GSAR imple-
ments the GSNCA method [20] that assesses multivari-
ate changes in the gene co-expression network between
two conditions but does not require network inference
step. Net correlation changes are estimated by introdu-
cing for each gene a weight factor that characterizes its
cross-correlations in the co-expression networks. Weight
vectors in both conditions are found as eigenvectors of
correlation matrices with zero diagonal elements. GSNCA
tests the hypothesis that for a gene set there is no dif-
ference in the gene weight vectors between two condi-
tions [20]. Package GSAR pairs the GSNCA method
with a graphical visualization that uses MSTs of the
correlation networks to examine the change in the cor-
relation structures of a gene set between two conditions
and highlight the most influential (hub) genes. This
visualization facilitates interpretation of changes in a
gene set.
In what follows we provide detailed description of the
methods implemented in package GSAR, which is avail-
able from the Bioconductor project [27], and illustrate
its potential applications. The similarity and differences
between GSAR and other methods, implementing GSA
approaches (mostly available as Bioconductor packages)
are summarized in Additional file 1: Table S1.
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Implementation
Package GSAR has been implemented in R [27] and em-
ploys the igraph class in package igraph [28] to handle
and manipulate graph objects. Some of its implemented
methods were developed and tested in [10, 20] and
others are novel. Some of the methods in package GSAR
are based on the multivariate generalizations of the
Wald-Wolfowitz (WW) and Kolmogorov-Smirnov (KS)
tests presented in [29]. All the statistical tests imple-
mented are non-parametric in a sense that significance
is estimated using sample permutations. A schematic
overview of package GSAR is shown in Fig. 1. The mini-
mum required input to any GSAR function that tests a
single gene set consists of: (1) a gene expression matrix
with p genes (rows) and N = n1 + n2 samples (columns);
and (2) sample labels indicating to which phenotype
each sample belongs in a form of integer numbers 1 and
2. All statistical methods return results as a list including
P-values, test statistics for observed samples, and test
statistics for permuted samples.
Hypothesis testing
Consider two different biological phenotypes (conditions),
with n1 samples of measurements for the first and n2








measurements of p gene expressions of a gene set
(pathway) in two phenotypes where sample X.j(Y.j) is
the jth p-dimensional vector in one phenotype. Let X, Y
be independent and identically distributed with the dis-
tribution functions Fx, Fy, p-dimensional mean vectors
μx and μy, and p × p positive-definite and symmetric co-
variance matrices Cx and Cy. Statistical methods in
package GSAR can test specific alternative hypotheses.
Figure 2 illustrates these different alternative hypotheses
Fig. 1 GSAR package outline. The inputs for the statistical tests can be (1) the matrix of gene expression for a single gene set in the form of
normalized microarray or RNA-seq data and a vector of labels indicating to which condition each sample belongs; or (2) the matrix of gene expression
for all genes, a vector of labels indicating to which condition each sample belongs, and a list of gene sets. Each test returns P-value and, optionally, the
test statistic of observed data, test statistic for all permutations, and other optional outputs. Some functions produce graph plots
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using the simple example of a bivariate normal distribu-
tion which represent a gene set of size p = 2. The standard
bivariate normal distribution shown in panel A of Fig. 2 is
compared to the different alternatives shown in panels B,
C, D, and E which show different distribution, mean
(shift), variance (scale), and correlation as compared to
panel A. Some alternative hypotheses are more specific
than others. For example, different mean or variance
implies different distribution; however the opposite is
not necessarily true.
Minimum spanning tree (MST)
The p-dimensional N samples from two phenotypes X
and Y can be represented by an edge-weighted undirected
graph G(V,E) with vertices V = {v1,⋯, vN} corresponding
to samples and edge weights estimated by the Euclidean
distance between samples in the Rp space. The minimum
spanning tree (MST) of a graph G(V,E) is defined as the
acyclic subset of edges T1 E that is selected from the full
set of N(N-1)/2 possible edges in the graph to connect all
N vertices such that
P
i;j∈T 1d vi; ; vj
 
is minimal [29]. The
distance between vertices i and j in the MST, d(vi, vj), cor-
relates with their distance in Rp. This property allows the
multivariate generalization of multiple univariate test sta-
tistics so they could be used for p-dimensional expression
data of gene sets. The MST is built using a standard
function from package igraph where the used algorithm
is selected automatically. For weighted graphs, Prim’s
algorithm is chosen.
Required input
The required input for all the test functions in the package
GSAR can be in two modes: (1) single gene set mode,
where the matrix of gene expressions (or other gene-related
measurements, e.g., protein abundances) for a single
gene set and a numeric vector specifying the experi-
mental group or condition for each sample are pro-
vided; (2) multiple gene sets mode, where the full
matrix of gene expressions, a numeric vector specify-
ing the experimental condition, and a list of gene sets
(each item is a character vector of gene identifiers) are
provided (function TestGeneSets).
Data and examples
A processed version of the p53 dataset is included in the
package for demonstration and can be loaded using
data(p53DataSet). This dataset comprises 50 samples of
the NCI-60 cell lines: 17 cell lines carrying wild type
(WT) TP53 and 33 cell lines carrying mutated (MUT)
TP53 [30]. Transcriptional profiles obtained from Affyme-
trix microarrays (platform hgu95av2) were downloaded
from the Broad Institute's website. The processing steps
are listed in the reference manual and the package vi-
gnette (see Additional file 2). The vignette also demon-
strates the use of different tests in GSAR using the ALL
(microarray) and Pickrell (RNA-seq) datasets, available re-
spectively from the Bioconductor data packages ALL and
tweeDEseqCountData.
Fig. 2 An example of bivariate normal distribution illustrating specific
alternative hypotheses for a hypothetical gene set of size p = 2. a The
standard bivariate normal distribution; b differential distribution as
compared to panel A; c differential mean (shift) as compared to
panel A; d differential variance (scale) as compared to panel A;
e differential correlation between two components as compared to
panel A. While the left-side panel shows three-dimensional density
plots, the right-side panel shows the corresponding contour plots
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Results and discussion
This Section presents the statistical methods available in
package GSAR that test different statistical hypotheses.
Several examples based on simulated and real datasets
illustrate methods application.
Multivariate Wald-Wolfowitz test
In the multivariate WW test, the MST is constructed
and all the edges connecting two vertices from different
phenotypes are removed to split the MST into disjoint
trees. The standardized number of remaining disjoint
trees (R) is used as the test statistic [10, 29]
W ¼ R−E R½ ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
var Rð Þp
The null distribution is estimated by permuting sample
labels and calculating R for a large number of times M.
The null distribution is asymptotically normal and H0 is
rejected for a small number of subtrees [29]. The signifi-
cance (P-value) is calculated as
P−valueWW ¼
XM
k¼1 I Wk≤Wobs½  þ 1
M þ 1
where Wk is the test statistic of permutation k, Wobs is
the observed test statistic from the original data and I[.]
is an indicator function. Function WWtest in package
GSAR implements this method, testing the null hypoth-
esis H0 : FX = FY against the alternative H1 : FX ≠ FY,
where FX and FY are the distribution functions of X and
Y, respectively. The following R command implements
the method
WWtest(object, group, nperm = 1000, pvalue.only =
TRUE)
where object is a numeric matrix of gene expression
with columns and rows corresponding to samples and
genes, respectively, group is a numeric vector (with
values 1 and 2) indicating group associations for sam-
ples, nperm is the number of permutations used to esti-
mate the null distribution, and pvalue.only is a logical
parameter that indicates if returning the P-value only is
desired. When pvalue.only = FALSE, the observed statis-
tic, the vector of permuted statistics, and the P-value are
returned in a list (see Additional file 2 for examples of
real dataset analysis).
Figure 3 presents two illustrative examples: (1) The
MST of the pooled samples of X, Y ~ N(0p×1,Ip×p) (H0 is
true) is shown in panel A and its disjoint subtrees (R =
27) are shown in panel B; (2) The MST of the pooled
samples of X ~ N(0p×1,Ip×p) and Y ~ N(1p×1,Ip×p) (H0 is
Fig. 3 Two illustrative examples of the disjoint MST subtrees. (1) The MST of the pooled samples of X, Y ~ N(0p×1,Ip×p) (H0 is true) is shown in panel
a and its 27 disjoint subtrees (R = 27) are shown in panel b; (2) The MST of the pooled samples of X ~ N(0p×1,Ip×p) and Y ~ N(1p×1,Ip×p) (H1 is true) is
shown in panel c and its 3 disjoint subtrees (R = 3) are shown in panel d
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false) is shown in panel C and its disjoint subtrees (R = 3)
are shown in panel D. 0p×1 and 1p×1 are p-dimensional
mean vectors of zeros and ones, and Ip×p is the p × p iden-
tity matrix. Applying function WWtest to these two cases
yields P-value = 0.813 and P-value < 0.001, respectively.
Multivariate Kolmogorov-Smirnov and mean deviation
tests
The vertices in the MST are ranked based on a specific
scheme and the test statistic is calculated based on these
ranks. Package GSAR supports two statistics: (1) The
Kolmogorov-Smirnov (KS) statistic which calculates the
maximum deviation between the Cumulative Distribu-
tion Functions (CDFs) of the ranks between X and Y
samples, i.e., the maximum absolute difference between
the number of observations from X and Y ranked lower










di ¼ rin1 −
si
n2
and ri(si) is the number of vertices (observations) in
X(Y) ranked lower than i; (2) The mean deviation (MD)
statistic which calculates the average deviation between
the CDFs of the ranks between X and Y samples. The
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rj is the rank of sample j in the MST and the exponent α
is set to 0.25 to give the ranks a modest weight. Al-
though the MD statistics use sample ranks here, a simi-
lar statistic that calculates the average deviation of CDFs
of gene ranks between a gene set and its complement
has been used successfully in the context of single sam-
ple gene set enrichment analysis [5, 31]. For both KS
and MD statistics, the null distribution is estimated by
permuting sample labels and calculating the statistic D
for a large number of times M. While the MD statistic
has asymptotically a normal distribution and tests a two-
sided hypothesis, the KS statistic asymptotically follows
the Smirnov distribution [29] and tests a one-sided hy-








k¼1 I Dk≥Dobs½  þ 1
M þ 1
Sample ranking scheme in the MST can be designed
to confine a specific alternative hypothesis more power.
Two alternatives are currently considered in GSAR.
First, functions KStest and MDtest test the null hypoth-
esis H0 : μX ¼ μY against the alternative H1 : μX≠μY .
The MST is rooted at a vertex with the largest geodesic
distance (i.e., one of two vertices that form the ends of
the longest path in the tree) and the rest of the vertices
are ranked according to the high directed preorder
(HDP) traversal of the tree [10, 29]. Function HDP.rank-
ing in package GSAR returns the vertices ranks in a
MST according to the HDP traversal. Second, the radial
Kolmogorov-Smirnov (function RKStest) and radial
mean deviation (function RMDtest) methods test the
null hypothesis H0: var(X) ≠ var(Y) against the alterna-
tive H1: var(X) ≠ var(Y) or equivalently H0 : σX ¼ σY
against H1 : σX≠σY where σX and σY are respectively
the standard deviations of X and Y. The MST is rooted
at the vertex of smallest geodesic distance (centroid) and
vertices are ranked based on their depth and distance
from the root such that ranks are increasing radially
from the root (function radial.ranking). Although the
power analysis in [10] showed that the radial ranking
scheme provides the differential variance hypothesis with
higher detection power than the differential mean hy-
pothesis, yet the power of detecting the latter alternative
is non-negligible. To attain higher confidence in the
results of RKS or RMD methods, they can be supple-
mented by KS or MD methods and then only the gene
sets that satisfy: P-valueRKS < α and P-valueKS > α (or
P-valueRMD < α and P-valueMD > α) should be considered.
Then the null will be rejected when the alternative H1 :
σX≠σY is true but not the alternative H1 : μX≠μY . The
following R commands implement the KS, MD, RKS, and
RMD methods
KStest(object, group, nperm= 1000, pvalue.only = TRUE)
MDtest(object, group, nperm= 1000, pvalue.only = TRUE)
RKStest(object, group, mst.order = 1, nperm = 1000,
pvalue.only = TRUE)
RMDtest(object, group, mst.order = 1, nperm = 1000,
pvalue.only = TRUE)
where object is a numeric matrix of gene expression
with columns and rows corresponding to samples and
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genes, respectively, group is a numeric vector (with values
1 and 2) indicating group associations for samples, nperm
is the number of permutations used to estimate the null
distribution, mst.order is a numeric value indicating the
number of MSTs considered in the radial ranking proced-
ure (see the union of MSTs subsection below for further
details), and pvalue.only is a logical parameter that indi-
cates if returning the P-value only is desired. When
pvalue.only = FALSE, the observed statistic, the vector
of permuted statistics, and the P-value are returned in a
list (see Additional file 2 for examples of real dataset
analysis).
Figure 4 presents two illustrative examples using nor-
mal (23 samples) and clear cell renal cell carcinoma (32
samples) samples from a real gene expression dataset
[32] that is available from the gene expression omnibus
repository (accession number GSE15641). Selected gene
sets from the Kyoto encyclopedia of genes and genomes
(KEGG) [33] were obtained from the curated collection
of the molecular signatures database (MSigDB) [34]. The
MST of the pooled normal and tumor samples, consider-
ing 67 genes from the KEGG ‘renal cell carcinoma’ gene
set is shown in panel A. The samples of each phenotype
are grouped together in the tree, suggesting separation be-
tween the two phenotypes in Rp. The KS test rejects the
null hypothesis (H1 : μX≠μY is true) while the RKS test
fails to do so. The MST of the pooled samples, consid-
ering 19 genes from the KEGG ‘Glycosylphosphatidyli-
nositol anchor biosynthesis’ gene set is shown in panel
B. Normal samples constitute the backbone of the MST
while tumor samples form the branches. The centroid
vertex in the MST naturally occupies the center of the
backbone and hence the difference in ranks is large be-
tween the two phenotypes. The RKS test rejects the
null hypothesis (H1 : σX≠σY is true), while the KS test
fails. The HDP and radial rankings of vertices in the
MST are shown above and below the vertices in both
panels. While most vertices are represented by circles,
the roots of the HDP and radial rankings are highlighted
as rectangular and square shapes, respectively.
Aggregated F-test of variance
The univariate F-test is used to find differential variability
in individual genes similar to [12]. The F-statistic for
gene i, Fi ¼ σXi=σY i , represents the ratio between the
phenotype variances and follows the F-distribution with
n1-1 and n2-1 degrees of freedom when the null hy-
pothesis H0 : σXi ¼ σY i is true for gene i. The null hy-
pothesis is rejected if Fi is too large or too small. Then
individual P-values for the genes in a gene set are ag-
gregated to obtain a score statistic. Comparisons among
Fig. 4 Two illustrative examples using 23 normal samples and 32 clear cell renal cell carcinoma samples from the GSE15641 dataset. a The MST
of the pooled normal and tumor samples considering 67 genes from the KEGG renal cell carcinoma gene set. The samples of each phenotype are
grouped together in the tree and the KS test rejects the null (H1 : μX≠μY is true) but not RKS test; b The MST of the pooled normal and tumor
samples considering 19 genes from the KEGG glycosylphosphatidylinositol (GPI) anchor biosynthesis gene set. Normal samples constitute the backbone
of the MST while tumor samples form the branches and RKS test rejects the null (H1 : σX≠σY is true) but not KS test. The roots of the HDP and radial
ranking schemes in the MSTs are highlighted with rectangle and square shapes, respectively
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aggregation methods such as Fisher’s probability combin-
ing method, Stouffer’s method, and Gamma method in
the context of DE analysis determined that Fisher’s
method performed best in terms of power and Type I
error rate [9, 35]. Assigning all individual P-values (Pi, 1 ≤
i ≤ p) equal weights, function aggrFtest uses Fisher’s









When all P-values are independent, the test statistic T
follows the Chi-square distribution with 2p degrees of
freedom. Since independence assumption is often vio-
lated for expression data, significance is estimated by
permuting sample labels and calculating T many times
(M). P-value is the proportion of permutations yielding
equal or more extreme statistic than the one obtained
from the original observed data, i.e.,
P−valueaggrFtest ¼
XM
k¼1I Tk≥Tobs½  þ 1
M þ 1
This method tests the null hypothesis that all genes
in the gene set show no differential variance between
two conditions against the alternative hypothesis that
at least one gene shows differential variance, i.e., the
null ∀i : σXi ¼ σY i where 1 ≤ i ≤ p against the alterna-
tive ∃i : σXi≠σY i . The following R command imple-
ments the method
AggrFtest(object, group, nperm = 1000, pvalue.only =
TRUE)
The command parameters are exactly the same as de-
fined above for other methods.
Gene sets net correlations analysis
The GSNCA method detects the differences in net cor-
relation structure for a gene set between two conditions
[20] and is implemented in function GSNCAtest. The
genes under each phenotype are assigned weight factors
which are adjusted simultaneously such that equality is
achieved between each gene’s weight and the sum of its







where rij is the correlation coefficient between genes i
and j. The problem is solved as an eigenvector problem
with a unique solution which is the eigenvector corre-
sponding to the largest eigenvalue of the genes’ correl-
ation matrix [20]. The test statistic wGSNCA is the first
norm between the two scaled weight vectors under two
phenotypes where each vector is multiplied by its norm.
This statistic tests the null hypothesis H0 :wGSNCA = 0
against the alternative H1 :wGSNCA ≠ 0 and detects
changes in the intergene correlations structure between
two phenotypes. This test differs from other methods
like GSCA and dCoxS that detect any changes in the
correlation matrix, i.e., H0 : CX =CY against the alterna-
tive H1 : CX ≠ CY, in the sense that it detects how correla-
tions change relative to each other. For example, when
CX = a CY and a is constant, eigenvectors of of CX and
CY are identical, however they have different eigenvalues
and average difference in pairwise correlations between
the two conditions. Hence GSCA detects differential
correlation but GSNCA does not detect change in the
net correlation structure. The following R command im-
plements the method (see Additional file 2 for examples
of real dataset analysis)
GSNCAtest(object, group, nperm= 1000, cor.method =
"pearson", check.sd =TRUE, min.sd = 1e-3, max.skip = 10,
pvalue.only = TRUE)
where check.sd is a logical parameter indicating if the
standard deviations of gene expressions should be checked
for small values before intergene correlations are com-
puted, min.sd the minimum allowed standard deviation
for any gene in the gene set where execution stops and an
error message is returned if the condition is violated,
max.skip is maximum number of skipped random permu-
tations which yield any gene with a standard deviation less
than min.sd, and cor.method is a character string indicat-
ing which correlation coefficient is used to calculate inter-
gene correlations (Pearson, Spearman or Kendall). The
rest of the parameters are exactly the same as defined
earlier for other methods.
The need to guard against zero standard deviation arises
in the case of RNA-seq count data where non-expressed
genes may yield zero counts across most samples and pro-
duce zero or tiny standard deviation for one or more genes
in the gene set. Such situation produces an error while com-
puting the correlation coefficients between genes. When
check.sd =TRUE, standard deviations are checked in ad-
vance and if any is smaller than min.sd (default is 10-3), the
execution stops and an error message is returned indicating
the number of feature causing the problem. Another similar
problem arises when non-expressed genes yield zero counts
across some samples under two phenotypes. Permuting
sample labels may group such zero counts under one
phenotype by chance and produce a standard deviation
smaller than min.sd. To allow the method to skip such per-
mutations without causing excessive delay, an upper bound
is set for the number of allowed skips (max.skip). If the
upper limit is exceeded, an error message is returned.
The union of MSTs
The second MST is defined as the MST of the full net-
work after excluding the links of the first MST, i.e., the
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subgraph G(V,E-T1). Package GSAR provides function
findMST2 to find the union of the first and second
MSTs (referred to by MST2). The wrapper function
plotMST2.pathways plots the MST2 of a gene set under
two conditions side-by-side to facilitate the comparison
between the correlation structure and hub genes. A gene
with high intergene correlations in the set tends to oc-
cupy a central position and has relatively high degree in
the MST2 because the shortest paths connecting the
vertices of the first and second MSTs pass through such
gene. In contrast, a gene with low intergene correlations
occupies a non-central position and has low degree (typ-
ically 2). This property of the MST2 makes it a valuable
visualization tool to examine the full correlation network
by highlighting the most highly correlated genes. We il-
lustrate the MST2 approach by considering selected
gene sets from the p53 dataset.
Figure 5 shows the MST2 of the ‘Lu tumor vasculature
up’ gene set obtained from the C2 collection (version
3.0) of curated gene sets in the MSigDB [34]. This gene
set consists of genes over-expressed in ovarian cancer
endothelium and was detected by GSNCA (P-value <
0.05) but not by GSCA (P-value > 0.05) [20]. The MST2
in Fig. 5a (wild type p53) identifies gene TNFAIP6
(tumor necrosis factor, α-induced protein 6) as a hub
genes. This gene was found to be 29.1 fold over-
expressed in tumor endothelium, and was suggested to
be specific for ovarian cancer vasculature [37]. Identify-
ing TNFAIP6 as a hub gene in this gene set suggests that
it could be an important regulator of ovarian cancer and
supports the original observation. The MST2 in Fig. 5b
(mutated p53) identifies gene VCAN (Versican) as a hub
gene. VCAN is involved in cell adhesion, proliferation,
angiogenesis and plays a central role in tissue morpho-
genesis and maintenance and its increased expression is
observed for tumor growth in multiple tissue types [38, 39].
This gene contains p53 binding sites and its expression cor-
relates with p53 dosage [40]. Hence, the role of both hub
genes identified by MST2 (TNFAIP6 and VCAN) and pre-
vious findings in the literature support identifying them as
hubs by the MST2 and indicates the usefulness of MST2 in
provide information regarding the underlying biological
processes in well-defined gene sets.
In addition to gene expression data, MST2 can be
informative in deciphering the properties of protein-
protein interaction (PPI) networks by highlighting the
Fig. 5 MST2 of the Lu tumor vasculature up gene set obtained from the C2 collection of curated gene sets in MSigDB. a wild type p53 samples
show TNFAIP6 as the hub gene; b mutated p53 samples show VCAN as the hub gene
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minimum set of essential interactions among proteins.
PPI networks can be represented by graphs with un-
directed binary edges and the adjacency matrix is used
here instead of the correlation matrix to find the
MST2. Figure 6 (reproduced with permission from
[41]) shows the yeast PPI network constructed using
information retrieved from PINA [42] and String [43]
databases of interactions. Panel A shows the first-
degree neighborhoods around the DBP2 yeast helicase
and panel B shows its MST2. While the full network
of first-degree neighborhoods appears crowded and
disordered, the corresponding MST2 representation
reveals fine network structure with highly connected
molecular chaperons, protein modifiers and regulators
occupying central positions (e.g., UBI4 and SSB1) [41].
Functions RKStest and RMDtest can also use the union
of the first k MSTs (1 < k ≤ 5) instead of the first MST to
include more links before performing their ranking pro-
cedure to achieve higher detection power. Generally,
power gain diminishes when k > 3 and including higher
order MSTs achieves no benefit.
Computational considerations
Non-parametric methods have longer execution time as
compared to parametric methods, however they are ne-
cessary whenever distributional assumptions are vio-
lated. Additional file 1: Table S2 provides an assessment
of the execution times expected when selected methods
from package GSAR are used with different sample size
and gene set size parameters. Additional file 1 also pre-
sents a simple example with R code performing parallel
computing of a selected group of gene sets from the
first case study in Additional file 2. Parallel computing
of large groups of gene sets reduces execution times
significantly and is possible whenever multiple core ma-
chines or high performance computing (HPC) facilities
are accessible.
Conclusions
Bioconductor package GSAR provides a set of statistical
methods for analyzing omics datasets. The package also
implements a convenient graphical visualization tool to
aid in deciphering the hidden structures in complex net-
works. The methods in package GSAR are applicable to
any type of omics data that can be represented in a
matrix format.
Additional files
Additional file 1: Additional document presenting computational
considerations and uniqueness of package GSAR. (DOCX 32 kb)
Additional file 2: Vignette of package GSAR. (PDF 732 kb)
Additional file 3: Source file ‘GSAR_1.9.1.tar.gz’. (GZ 2174 kb)
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